Abatacept + Adalimumab Afzb Interaction

Majorinteraction on record

Description

Increased risk of serious infection when combined with TNF blockers. Use not recommended in patients with RA due to no added benefit.

Mechanism

TNF blocker combined with other biologic immunosuppressant

Source: NLP:adalimumab-afzb